BMP3 and colorectal carcinoma: Furthermore, a 4-biomarker panel was the only one combining methylated BMP3, NDRG4, SDC2 with FOBT (and not FIT), achieving a moderately good performance for detection of CRC, 85.4% sensitivity and 92% specificity, and all adenomas (85.7% sensitivity).